Surgical Science Sweden AB Statistics
Want to see SE:SUS full AI Analyst Report?
Surgical Science Sweden AB (SUS) Stock Statistics & Valuation Metrics
Total Valuation
Surgical Science Sweden AB has a market cap or net worth of SEK 3.09B. The enterprise value is SEK 964.04M.
- Market Cap
- SEK 3.09B
- Enterprise Value
- SEK 964.04M
Share Statistics
Surgical Science Sweden AB has 51,026,237 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 51,026,237
- Owned by Insiders
- ―
- Owned by Institutions
- 0.10%
Financial Efficiency
Surgical Science Sweden AB’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is 1.64%.
- Return on Equity (ROE)
- 0.02
- Return on Assets (ROA)
- 0.01
- Return on Invested Capital (ROIC)
- 1.64%
- Return on Capital Employed (ROCE)
- 0.02
- Revenue Per Employee
- 3.11M
- Profits Per Employee
- 209.46K
- Employee Count
- 319
- Asset Turnover
- 0.21
- Inventory Turnover
- 2.02
Valuation Ratios
The current PE Ratio of Surgical Science Sweden AB is 34.07. Surgical Science Sweden AB’s PEG ratio is 30.83.
- PE Ratio
- 34.07
- PS Ratio
- 3.11
- PB Ratio
- 0.70
- Price to FCF
- 30.00
- Price to Operating Cash Flow
- 21.33
- PEG Ratio
- 30.83
Income Statement
In the last 12 months, Surgical Science Sweden AB had revenue of 992.34M and earned 66.82M in profits. Earnings per share was 1.31.
- Revenue
- 992.34M
- Gross Profit
- 576.90M
- Operating Income
- 108.97M
- Pretax Income
- 100.14M
- Net Income
- 66.82M
- EBITDA
- 192.34M
- Earnings Per Share (EPS)
- 1.31
Cash Flow
In the last 12 months, operating cash flow was 149.13M and capital expenditures -43.08M, giving a free cash flow of 106.05M billion.
- Operating Cash Flow
- 149.13M
- Free Cash Flow
- 106.05M
- Free Cash Flow per Share
- 2.08
Dividends & Yields
Surgical Science Sweden AB pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 3.33%
- Earnings Yield
- 2.93%
Stock Price Statistics
- Beta
- 0.56
- 52-Week Price Change
- -24.88%
- 50-Day Moving Average
- 53.44
- 200-Day Moving Average
- 38.26
- Relative Strength Index (RSI)
- 72.53
- Average Volume (3m)
- 212.24K
Important Dates
Surgical Science Sweden AB upcoming earnings date is Nov 12, 2026, Before Open (Not Confirmed).
- Last Earnings Date
- Nov 12, 2026
- Next Earnings Date
- Nov 12, 2026
- Ex-Dividend Date
- ―
Financial Position
Surgical Science Sweden AB as a current ratio of 4.07, with Debt / Equity ratio of 1.85%
- Current Ratio
- 4.07
- Quick Ratio
- 3.36
- Debt to Market Cap
- 0.01
- Net Debt to EBITDA
- -2.79
- Interest Coverage Ratio
- 17.34
Taxes
In the past 12 months, Surgical Science Sweden AB has paid 33.32M in taxes.
- Income Tax
- 33.32M
- Effective Tax Rate
- 0.33
Enterprise Valuation
Surgical Science Sweden AB EV to EBITDA ratio is 10.81, with an EV/FCF ratio of 23.82.
- EV to Sales
- 2.47
- EV to EBITDA
- 10.81
- EV to Free Cash Flow
- 23.82
- EV to Operating Cash Flow
- 16.94
Balance Sheet
Surgical Science Sweden AB has SEK 658.39M in cash and marketable securities with SEK 2.86M in debt, giving a net cash position of SEK 655.53M billion.
- Cash & Marketable Securities
- SEK 658.39M
- Total Debt
- SEK 2.86M
- Net Cash
- SEK 655.53M
- Net Cash Per Share
- SEK 12.85
- Tangible Book Value Per Share
- SEK 19.36
Margins
Gross margin is 62.24%, with operating margin of 13.77%, and net profit margin of 9.11%.
- Gross Margin
- 62.24%
- Operating Margin
- 13.77%
- Pretax Margin
- 12.33%
- Net Profit Margin
- 9.11%
- EBITDA Margin
- 22.86%
- EBIT Margin
- 14.14%
Analyst Forecast
The average price target for Surgical Science Sweden AB is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 8.40%
- EPS Growth Forecast
- 0.74%
Scores
- Smart Score
- ―
- AI Score
- 73
